Skip to main content

Genetic tests

09
Feb 2024

New national catalog for genetic tests released in Spain

On January 23, 2024, the Ministry of Health introduced a new national catalog, which guarantees the Spanish population's genetic tests nationwide. Currently, the catalog includes 672 tests in eight disease areas, including adult and pediatric oncohematology, pharmacogenomics, hereditary metabolic and mitochondrial diseases, and others. Twelve more disease areas are expected to be added in 2024.
06
Feb 2024

Eight NHS Genomic Networks of Excellence launched in England

In January 2024, eight NHS Genomic Networks of Excellence were launched within the NHS Genomic Medicine Service (GMS). NHS England is funding these innovative networks to develop the evidence and model of adoption for cutting-edge genomic advances and technology applications and inform commissioning decisions.
01
Feb 2024

2024/25 National Genomic Test Directory released in England

In January 2024, NHS England issued an updated version of the National Genomic Test Directory for 2024/2025, which lists genomic tests commissioned by NHS England via Genomic Laboratory Hubs. Six new codes (test-indication combinations) were introduced in the Test Directory for cancer, and four new codes in the Test Directory for rare and inherited diseases.
18
Sep 2023

New version of the CCAM Nomenclature published in France

At early September 2023, the new version of the classification of procedure codes (CCAM v.73) was published. Several changes were introduced, including the creation of two permanent codes, one provisionally registered code, and three new grouping codes for 280 dental procedures.
07
Sep 2023

Launch of the national newborn screening for spinal muscular atrophy in Sweden

On August 30, 2023, the National Board of Health and Welfare introduced national screening for spinal muscular atrophy (SMA) in newborns. The screening test will identify children with homozygous deletion in the SMN1 gene and 1–3 copies of the SMN2 gene. As a result, those affected by the most severe forms of SMA can receive treatment before the onset of symptoms.
24
Jul 2023

Extended reimbursement for next-generation sequencing (NGS) in Belgium

In late June 2023, the National Institute for Health and Disability Insurance (INAMI-RIZIV) decided to extend reimbursement for molecular biology tests by next-generation sequencing (NGS) for one year until June 30, 2024. NGS in oncology and hemato-oncology are temporarily reimbursed as a pilot under a specific agreement (Convention) with INAMI-RIZIV from 2019.
19
Jun 2023

Update of the National Genomic Test Directory in England

On June 1, 2023, NHS England issued an updated version of the National Genomic Test Directory, which lists genomic tests commissioned by NHS England via Genomic Laboratory Hubs. Three new codes (test-indication combinations) were introduced in the Test Directory for rare and inherited diseases.